February 17, 2013 in Business

The CoAxia catheter-based device with inflatable balloons helps redirect blood flow from the lower extremities to the head to help stroke patients. The company spent more than $70 million to win approval from the FDA, only to run into a regulatory wall.


Please keep it civil. Don't post comments that are obscene, defamatory, threatening, off-topic, an infringement of copyright or an invasion of privacy. Read our forum standards and community guidelines.

You must be logged in to post comments. Please log in here or click the comment box below for options.

comments powered by Disqus